II. Eczematous and immunologic diseases.
D000818:Animals; D003876:Dermatitis, Atopic / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D003877:Dermatitis, Contact / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D003880:Dermatology / Q000639:trends; D004485:Eczema / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000628:therapy; D012107:Research Design; D012872:Skin Diseases, Vesiculobullous / Q000276:immunology / Q000628:therapy; D014581:Urticaria / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D014657:Vasculitis / Q000276:immunology / Q000628:therapy